Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Total Enrollment
60 participants
Study Classification
OBSERVATIONAL
Study Start Date
2006-05-31
Study Completion Date
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will use the Conception Kit in their home and fill out a 22 question questionnaire in order to demonstrate their knowledge of the method of usage as described in the instructions and on the website: www.conceptionkit.com.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
NCT02176239
Primary Immunodeficiency Disease (PIDD)
COMPLETED
Human Factors Usability Study of Ib2C Conception System
NCT01564940
Cervical Cap Insemination
COMPLETED
Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers
NCT03133351
Coagulation
UNKNOWN
Period Tracker at Home Study
NCT05088382
Menstrual Cycles
COMPLETED
Clinical Evaluation of the Next Generation Venue Ultrasound System, Components, and Accessories - Canada
NCT03653572
Ultrasound Use in Emergency/Medical Care
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be given a Conception Kit and take the Kit home and read the instructions and if needed consult the website. The patient will then complete a 22 question questionnaire in order to demonstrate their knowledge of the method of use.
All Components have 510K clearance. This study is a validation of the instructions for use (IFU) only.
OPK Class I Device 21CFR 862.1485, Conception Cap K993953, Pregnancy Test Kit K974059, Semen Collection Device K902936 (21CFR 884.5300),
Conception Kit has CE Marked by GMED. (Certificate 2037)
Conceivex is an ISO 13485: 2003 company
All Components have 510K clearance. This study is a validation of the instructions for use (IFU) only.
OPK Class I Device 21CFR 862.1485, Conception Cap K993953, Pregnancy Test Kit K974059, Semen Collection Device K902936 (21CFR 884.5300),
Conception Kit has CE Marked by GMED. (Certificate 2037)
Conceivex is an ISO 13485: 2003 company
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Healthy
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
NATURAL_HISTORY
Study Time Perspective
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who are actively trying to become pregnant
Exclusion Criteria
* Women who are contraindicated for a pregnancy
Minimum Eligible Age
16 Years
Maximum Eligible Age
55 Years
Eligible Sex
FEMALE
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Conceivex
INDUSTRY
Sponsor Role
lead
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael G La Vean
Role: STUDY_DIRECTOR
Study Coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Charles Barker
Belding, Michigan, United States
Site Status
Dr. Dorsey Ligon
Grand Rapids, Michigan, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Flierman PA, Hogerzeil HV, Hemrika DJ. A prospective, randomized, cross-over comparison of two methods of artificial insemination by donor on the incidence of conception: intracervical insemination by straw versus cervical cap. Hum Reprod. 1997 Sep;12(9):1945-8. doi: 10.1093/humrep/12.9.1945.
Reference Type
BACKGROUND
Coulson C, McLaughlin EA, Harris S, Ford WC, Hull MG. Randomized controlled trial of cervical cap with intracervical reservoir versus standard intracervical injection to inseminate cryopreserved donor semen. Hum Reprod. 1996 Jan;11(1):84-7. doi: 10.1093/oxfordjournals.humrep.a019044.
Reference Type
BACKGROUND
Subak LL, Adamson GD, Boltz NL. Therapeutic donor insemination: a prospective randomized trial of fresh versus frozen sperm. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1597-604; discussion 1604-6. doi: 10.1016/0002-9378(92)91548-o.
Reference Type
BACKGROUND
Williams DB, Moley KH, Cholewa C, Odem RR, Willand J, Gast MJ. Does intrauterine insemination offer an advantage to cervical cap insemination in a donor insemination program? Fertil Steril. 1995 Feb;63(2):295-8. doi: 10.1016/s0015-0282(16)57358-0.
Reference Type
BACKGROUND
Corrigan E, McLaughlin EA, Coulson C, Ford WC, Hull MG. The effect of halving the standard dose of cryopreserved semen for donor insemination: a controlled study of conception rates. Hum Reprod. 1994 Feb;9(2):330-3. doi: 10.1093/oxfordjournals.humrep.a138502.
Reference Type
BACKGROUND
Perino A, Cimino C, Catinella E, Barba G, Cittadini E. In vitro sperm capacitation and intrauterine insemination (IVC-Insem): a simple technique for the treatment of refractory infertility unrelated to female organic pelvic disease. Clinical results and immunological effects: a preliminary report. Acta Eur Fertil. 1986 Sep-Oct;17(5):325-31.
Reference Type
BACKGROUND
Corson SL, Batzer FR, Otis C, Fee D. The cervical cap for home artificial insemination. J Reprod Med. 1986 May;31(5):349-52.
Reference Type
BACKGROUND
Noci I, Chelo E, Scarselli G, Messori A. Cervical cap homologous artificial insemination (AIH): the University of Florence experience. Acta Eur Fertil. 1986 Mar-Apr;17(2):133-7.
Reference Type
BACKGROUND
Bergquist CA, Rock JA, Miller J, Guzick DS, Wentz AC, Jones GS. Artificial insemination with fresh donor semen using the cervical cap technique: a review of 278 cases. Obstet Gynecol. 1982 Aug;60(2):195-9.
Reference Type
BACKGROUND
Carruthers GB. Present-day management of male infertility. IPPF Med Bull. 1982 Jun;16(3):1-2.
Reference Type
BACKGROUND
Coucke W, Steeno O. Pregnancy rate after homologous insemination. Arch Androl. 1979;2(1):73-6. doi: 10.3109/01485017908987295.
Reference Type
BACKGROUND
Segal S, Sherer M. The use of donor mucus and insemination for cervical factor. Int J Fertil. 1979;24(4):291-2.
Reference Type
BACKGROUND
Jondet D, Millet D, Netter A. [Adaptation of a cervical cap for human artificial insemination]. J Gynecol Obstet Biol Reprod (Paris). 1975 Jan-Feb;4(1):141-4. French.
Reference Type
BACKGROUND
Meyer WR, Smith PM, Clark MR, Cusmano LL, Fritz MA. Therapeutic cup insemination with cryopreserved donor sperm: prognostic value of cervical mucus score at insemination and the number of motile sperm in mucus at 24 hours. Fertil Steril. 1996 Sep;66(3):435-9. doi: 10.1016/s0015-0282(16)58515-x.
Reference Type
BACKGROUND
Drobnis EZ, Clisham PR, Brazil CK, Wisner LW, Zhong CQ, Overstreet JW. Detection of altered acrosomal physiology of cryopreserved human spermatozoa after sperm residence in the female reproductive tract. J Reprod Fertil. 1993 Sep;99(1):159-65. doi: 10.1530/jrf.0.0990159.
Reference Type
BACKGROUND
Depypere HT, Gordts S, Campo R, Comhaire F. Methods to increase the success rate of artificial insemination with donor semen. Hum Reprod. 1994 Apr;9(4):661-3. doi: 10.1093/oxfordjournals.humrep.a138567.
Reference Type
BACKGROUND
Diamond MP, Christianson C, Daniell JF, Wentz AC. Pregnancy following use of the cervical cup for home artificial insemination utilizing homologous semen. Fertil Steril. 1983 Apr;39(4):480-4. doi: 10.1016/s0015-0282(16)46936-0.
Reference Type
BACKGROUND
Scott JZ, Nakamura RM, Mutch J, Davajan V. The cervical factor in infertility: diagnosis and treatment. Fertil Steril. 1977 Dec;28(12):1289-94. doi: 10.1016/s0015-0282(16)42971-7.
Reference Type
BACKGROUND
Hanson FW, Overstreet JW. The interaction of human spermatozoa with cervical mucus in vivo. Am J Obstet Gynecol. 1981 May 15;140(2):173-8. doi: 10.1016/0002-9378(81)90105-8.
Reference Type
BACKGROUND
O'Brien P, Vandekerckhove P. Intra-uterine versus cervical insemination of donor sperm for subfertility. Cochrane Database Syst Rev. 2000;(2):CD000317. doi: 10.1002/14651858.CD000317.
Reference Type
BACKGROUND
Mahony MC. Evaluation of the effect of a cervical cap device on sperm functional characteristics in vitro. Andrologia. 2001 Jul;33(4):207-13. doi: 10.1046/j.1439-0272.2001.00426.x.
Reference Type
RESULT
Adamson GD, Subak LL, Boltz NL, McNulty MA. Failure of intrauterine insemination in a refractory infertility population. Fertil Steril. 1991 Aug;56(2):361-3. doi: 10.1016/s0015-0282(16)54502-6.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Conception Kit
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Survey of Tourniquet Use in a Combat Support Hospital
NCT00517166
COMPLETED
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
NCT04393961
UNKNOWN
NA
Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD
NCT02167763
COMPLETED
PHASE1
OM2 Low Saturation Verification
NCT06661889
COMPLETED
RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection
NCT02714985
WITHDRAWN
Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters
NCT03679286
UNKNOWN
Technical Accuracy and Userfriendliness of a Point-Of-Care C Reactive Protein Device in a Nursing Home Setting
NCT02104999
COMPLETED
NA
Multicenter Performance Study of TriQuik Invitro Diagnostic Device
NCT05293821
UNKNOWN
The Stork OTC: Collection, Placement & Delivery
NCT02038322
COMPLETED
NA
Technical Accuracy and Userfriendliness of Two Point-of-care C Reactive Protein Devices in Comparison With Laboratory CRP Testing.
NCT01667172
COMPLETED
NA
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
NCT00780286
COMPLETED
PHASE1
Procalcitonin Test Reference Range Determination
NCT02591121
COMPLETED
Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older
NCT03074266
UNKNOWN
Usability Study of the Focus Touch™ Conception System: Semen Collection
NCT01585012
COMPLETED
EARLY_PHASE1
Koning Breast Computed Tomography Guided Biopsy
NCT01750320
COMPLETED
PHASE1
An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge
NCT06352125
COMPLETED
Compliant Analysis of Patient Samples and Data
NCT04364503
RECRUITING
Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
NCT06261580
COMPLETED
Histological Analysis of CelluJuve® Injections in the Brachium
NCT06930209
ACTIVE_NOT_RECRUITING
NA
Product Evaluation of a Newly Developed Intermittent Catheter.
NCT02966015
COMPLETED
NA
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
NCT02756234
COMPLETED
Pilot Evaluation of the StarGuide Next Generation SPECT/CT System
NCT07272161
NOT_YET_RECRUITING
NA
Users Study Of The Caverject Delivery System
NCT01747928
COMPLETED
EARLY_PHASE1